Improving the time-machine: Estimating date of birth of grade II gliomas

Cell Proliferation

Volumn 45, Issue 1, 2012, Pages 76-90

  Gerin, C ^a   Pallud, J ^b,g   Grammaticos, B ^a   Mandonnet, E ^a,c,g   Deroulers, C ^a   Varlet, P ^b   Capelle, L ^f,g   Taillandier, L ^d,g   Bauchet, L ^e,g   Duffau, H ^e,g   Badoual, M ^a  

^a CNRS   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d Nancy Neurological Hospital   (France)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g Réseau d'Etude des Gliomes REG ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER SIZE; CARCINOGENESIS; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; TIME;

CELL PROLIFERATION; GLIOMA; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NEOPLASM GRADING; TIME FACTORS;

EID: 84655163834     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00790.x     Document Type: Article

References (44)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114, 97-109.
2. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer W, Illig J (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neaplasms. J. Neurosurg. 66, 865-874.
3. Pallud J, Varlet P, Devaux B, Geha S, Badoual M, Deroulers C et al. (2010) Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurology 74, 1724-1731.
4. Keles GE, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J. Neurosurg. 95, 735-745.
5. Salgaller ML, Liau LM (2006) Current status of clinical trials for glioblastoma. Rev. Recent Clin. Trials 3, 265-281.
6. Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 4, 753-764.
7. Mandonnet E, Pallud J, Fontaine D, Taillandier L, Bauchet L, Peruzzi P et al. (2009) Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurg. Rev. 33, 91-96.
8. Ricard D, Kaloshi G, Amiel-Benouaich A, Lejeune J, Marie Y, Mandonnet E et al. (2007) Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann. Neurol. 61, 484-490.
9. Prabhu VC, Khaldi A, Barton KP, Melian E, Schneck MJ, Primeau MJ et al. (2010) Management of diffuse low-grade cerebral gliomas. Neurol. Clin. 28, 1037-1059.
10. Peyre M, Cartalat-Carel S, Meyronet D, Ricard D, Jouvet A, Pallud J et al. (2010) Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol. 12, 1078-1082.
11. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J. Clin. Oncol. 21, 1624-1636.
12. Swanson KR, Alvord EC, Murray JD (2000) A quantitative model for differential motility of gliomas in grey and white matter. Cell Prolif. 33, 317-329.
13. Jbabdi S, Mandonnet E, Duffau H, Capelle L, Swanson KR, Pelegrini-Issac M et al. (2005) Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging. Magn. Reson. Med. 54, 616-624.
14. Frieboes HB, Zheng X, Sun CH, Tromberg B, Gatenby R, Cristini V (2006) An integrated computational/experimental model of tumor invasion. Cancer Res. 66, 1597-1604.
15. Guiot C, Pugnot N, Delsanto PP, Deisboeck TS (2007) Physical aspects of cancer invasion. Phys. Biol. 4, 1-6.
16. Stein AM, Demuth T, Mobley D, Berens M, Sander LM (2007) A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment. Rep. Prog. Phys. 72, 356-365.
17. Gerisch A, Chaplain MA (2008) Mathematical modelling of cancer cell invasion of tissue: local and non-local models and the effect of adhesion. J. Theor. Biol. 250, 684-704.
18. Aubert M, Badoual M, Féreol S, Christov C, Grammaticos B (2006) A cellular automaton model for the migration of glioma cells. Phys. Biol. 3, 93-100.
19. Aubert M, Badoual M, Christov C, Grammaticos B (2008) A model for glioma cell migration on collagen and astrocytes. J. R. Soc. Interface 5, 75-83.
20. Deroulers C, Aubert M, Badoual M, Grammaticos B (2009) Modeling tumor cell migration: from microscopic to macroscopic models. Phys. Rev. E 79, 031917-1-031917-14.
21. Badoual M, Deroulers C, Aubert M, Grammaticos B (2010) Modelling intercellular communication and its effect on tumour invasion. Phys. Biol. 7, 046013.
22. Tanaka ML, Debinski W, Puri IK (2009) Hybrid mathematical model of glioma progression. Cell Prolif. 42, 637-646.
23. Murray JD (2002) Mathematical Biology. II: Spatial Models and Biomedical Applications, 3rd edn. Berlin: Springer-Verlag.
24. Tracqui P, Cruywagen GC, Woodward DE, Bartoo GT, Murray JD, Alvord EC (1995) A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth. Cell Prolif. 28, 17-31.
25. Cruywagen GC, Woodward DE, Tracqui P, Bartoo GT, Murray JD, Alvord EC (1995) The modelling of diffusive tumours. J. Biol. Syst. 3, 937-945.
26. Cook J, Woodward DE, Tracqui P, Cruywagen GC, Murray JD, Bartoo GT et al. (1995) Resection of gliomas and life expectancy. J. Neurooncol. 24, 131.
27. Burgess PK, Kulesa PM, Murray JD, Alvord EC (1997) The interaction of growth rates and diffusion coefficients in a three-dimensional mathematical model of gliomas. J. Neuropathol. Exp. Neurol. 56, 704.
28. Bondiau PY, Clatz O, Sermesant M, Marcy PY, Delinguette H, Frenay M et al. (2008) Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging. Phys. Med. Biol. 53, 879-893.
29. Harpold HL, Alvord EC Jr, Swanson KR (2007) The evolution of mathematical modeling of glioma proliferation and invasion. J. Neuropathol. Exp. Neurol. 1, 1-9.
30. Woodward DE, Cook J, Tracqui P, Cruywagen GC, Murray JD, Alvord EC (1996) A mathematical model of glioma growth: the effect of extent of surgical resection. Cell Prolif. 29, 269-288.
31. Swanson KR, Bridge C, Murray JD, Alvord EC Jr (2004) Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J. Neurol. Sci. 216, 289-296.
32. Powathil G, Kohandel M, Sivaloganathan S, Oza A, Milosevic M (2007) Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy. Phys. Med. Biol. 52, 3291-3306.
33. Rockne R, Rockhill JK, Mrugala M, Spence AM, Kalet I, Hendrickson K et al. (2010) Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modelling approach. Phys. Med. Biol. 55, 3271-3285.
34. Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H et al. (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann. Neurol. 53, 524-528.
35. Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D et al. (2006) Prognostic value of initial magnetic resonance imaging growth rates for world health organization grade II gliomas. Ann. Neurol. 60, 380-383.
36. Hlaihel C, Guilloton L, Guyotat J, Streichenberger N, Honnorat J, Cotton F (2010) Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. J. Neurooncol. 97, 73-80.
37. Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L et al. (2010) Natural history of incidental WHO grade II gliomas. Ann. Neurol. 68, 727-733.
38. Duffau H, Pallud J, Mandonnet E (2011) Evidence for the genesis of WHO grade II glioma in an asymptomatic young adult using repeated MRIs. Acta Neurochir. 153, 473-477.
39. Murray JD (2002) Mathematical Biology: I. An Introduction, 3rd edn. Berlin: Springer-Verlag.
40. Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R et al. (2009) Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro-oncology 11, 176-182.
41. Mandonnet E, Pallud J, Clatz O, Taillandier L, Konukoglu E, Duffau H et al. (2008) Computational modeling of the who grade II glioma dynamics: principles and applications to management paradigm. Neurosurg. Rev. 31, 263-269.
42. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP (1997) Oligodendrogliomas. part i: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J. Neurooncol. 34, 37-59.
43. Anderson AR, Chaplain MA (1998) Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60, 857-899.
44. Cooper MD, Tanaka ML, Puri IK (2010) Coupled mathematical model of tumorigenesis and angiogenesis in vascular tumours. Cell Prolif. 43, 542-552.